We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+6.09%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$9.47B
AUM Growth
-$610M
Cap. Flow
-$2.85B
Cap. Flow %
-30.08%
Top 10 Hldgs %
17.74%
Holding
1,739
New
479
Increased
297
Reduced
376
Closed
502

Sector Composition

Rank Sector Weight
1 Healthcare 9.6%
2 Consumer Discretionary 9%
3 Technology 7.67%
4 Communication Services 6.77%
5 Consumer Staples 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACOR
376
DELISTED
Acorda Therapeutics
ACOR
$2.77M 0.03%
675
+597
+765% +$2.57M
MSCC
377
DELISTED
Microsemi Corp
MSCC
$2.76M 0.03%
+113,855
New +$2.86M
MRO
378
DELISTED
Marathon Oil Corporation
MRO
$2.73M 0.03%
+78,403
New +$2.79M
COP icon
379
CALL
ConocoPhillips
COP
$147B
$2.73M 0.03%
39,200
+29,300
+296% +$1.95M
CATM
380
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$2.7M 0.03%
72,709
-75,255
-51% -$2.54M
DIS icon
381
Walt Disney
DIS
$167B
$2.66M 0.03%
+41,263
New +$2.65M
BMY icon
382
PUT
Bristol-Myers Squibb
BMY
$133B
$2.64M 0.03%
+57,000
New +$2.5M
BYI
383
PUT
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
$2.62M 0.03%
+36,400
New +$2.56M
ANN
384
DELISTED
ANN INC
ANN
$2.61M 0.03%
72,137
-49,407
-41% -$1.69M
MSFT icon
385
CALL
Microsoft
MSFT
$3.45T
$2.61M 0.03%
78,300
-13,500
-15% -$444K
NXGN
386
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$2.59M 0.03%
+119,202
New +$2.54M
TTMI icon
387
TTM Technologies
TTMI
$12B
$2.58M 0.03%
264,958
-70,897
-21% -$674K
VTRS icon
388
Viatris
VTRS
$20.4B
$2.58M 0.03%
+67,532
New +$2.38M
BAX icon
389
PUT
Baxter International
BAX
$13.5B
$2.57M 0.03%
71,983
+65,539
+1,017% +$2.54M
MTG icon
390
MGIC Investment
MTG
$6.16B
$2.53M 0.03%
347,994
+311,759
+860% +$2.21M
VNDA icon
391
Vanda Pharmaceuticals
VNDA
$307M
$2.53M 0.03%
+230,749
New +$2.47M
SKX
392
DELISTED
Skechers
SKX
$2.53M 0.03%
243,501
+166,143
+215% +$1.58M
GCVRZ
393
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.52M 0.03%
1,250,000
-100,000
-7% -$190K
CI icon
394
Cigna
CI
$73.7B
$2.51M 0.03%
+32,636
New +$2.55M
PHM icon
395
Pultegroup
PHM
$24.1B
$2.46M 0.03%
148,889
-3,124
-2% -$53.3K
SFL icon
396
SFL Corp
SFL
$1.64B
$2.45M 0.03%
+160,609
New +$2.51M
NUAN
397
DELISTED
Nuance Communications, Inc.
NUAN
$2.45M 0.03%
+151,446
New +$2.51M
ADSK icon
398
CALL
Autodesk
ADSK
$49.5B
$2.45M 0.03%
59,500
+18,900
+47% +$698K
MRK icon
399
CALL
Merck
MRK
$322B
$2.45M 0.03%
53,867
+9,746
+22% +$445K
HRB icon
400
H&R Block
HRB
$5.58B
$2.43M 0.03%
91,300
-679,416
-88% -$19.8M

Similar funds

Highbridge Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Highbridge Capital Management held 1,739 positions worth $9.47B, down 6.1% from $10.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Highbridge Capital Management withdrew a net $2.85B in Q3 2013, closing 502 positions and reducing 376 holdings. Its most notable exit was Cosan Limited, an estimated $397M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 9.6% of assets, up from 6.9% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Highbridge Capital Management opened a new position in Lowe's Companies worth $62M.

  • Highbridge Capital Management's largest Q3 2013 buy was Lowe's Companies: 1,303,303 shares worth $62M.
  • Highbridge Capital Management added most to Eastman Chemical in Q3 2013, an estimated $64.8M increase.
  • Highbridge Capital Management's biggest Q3 2013 reduction was Herc Holdings, cutting an estimated $116M.
  • Highbridge Capital Management fully exited Cosan Limited in Q3 2013, selling an estimated $397M.
  • Highbridge Capital Management's ten largest holdings make up 18% of its $9.47B portfolio in Q3 2013.
  • Highbridge Capital Management opened 479 new positions and closed 502 in Q3 2013.
  • Highbridge Capital Management's portfolio value fell 6.1% quarter-over-quarter to $9.47B.

Based on Highbridge Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.